Literature DB >> 25720446

The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond.

Anhar Hassan1,2, Samuel S Wu3, Peter Schmidt4, Tanya Simuni5, Nir Giladi6, Janis M Miyasaki7, Bastiaan R Bloem8, Irene A Malaty1, Michael S Okun1.   

Abstract

BACKGROUND: Parkinson's disease (PD) patients with 20 years or more survival (PD-20) are not well characterized.
OBJECTIVE: To evaluate PD-20 patient characteristics and identify areas for improvement of their health care.
METHODS: The international, multicenter National Parkinson's Foundation Quality Improvement Initiative (NPF-QII) study database was queried to identify PD-20 subjects. Demographic and clinical data were analyzed.
RESULTS: We identified 187 PD-20 subjects (55% men) representing 4% (187/4,619) of all NPF-QII participants. Subjects were mean age 69.5 years; mean age at PD onset was 44.0 years. The majority (75% ) had 20-25 years of PD duration, the longest duration being 49 years. They were median Hoehn and Yahr stage 3, and 75% had motor fluctuations. Half (54% ) reported exercising. The majority (89% ) were living at home and required a caregiver (88% ). They were mildly cognitively impaired for age (Montreal Cognitive Assessment estimate 22.6±3.7), with most deficits in verbal fluency and delayed recall. Quality of life (Parkinson's Disease Quality of Life Questionnaire index 36±15% ) was mild to moderately impaired, with most impairment in mobility and activities of daily living. Caregiver strain measured by the Multidimensional Caregiver Strain Index (27±16% ), recorded highest subscores in social constraint. PD-20 subjects aged <70 years versus ≥70 only differed significantly by worse cognition (P <  0.0001).
CONCLUSIONS: PD-20 subjects reflect an elite group of PD survivors with early-onset disease and relatively mild cognitive disability despite long disease duration. Interventions for caregivers, mobility, and activities of daily living are areas that could improve caregiver burden and patient quality of life.

Entities:  

Keywords:  Advanced; Parkinson’s disease; complications; quality-of-life

Mesh:

Year:  2015        PMID: 25720446     DOI: 10.3233/JPD-140515

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  11 in total

1.  Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.

Authors:  Kelly A Mills; Zoltan Mari; Gregory M Pontone; Alexander Pantelyat; Angela Zhang; Nadine Yoritomo; Emma Powers; Jason Brandt; Ted M Dawson; Liana S Rosenthal
Journal:  Parkinsonism Relat Disord       Date:  2016-09-27       Impact factor: 4.891

2.  Community Exercise: A New Tool for Personalized Parkinson's Care or Just an Addition to Formal Care?

Authors:  Josefa Domingos; John Dean; Júlio Belo Fernandes; João Massano; Catarina Godinho
Journal:  Front Syst Neurosci       Date:  2022-06-30

3.  Profile of social self-management practices in daily life with Parkinson's disease is associated with symptom severity and health quality of life.

Authors:  Linda Tickle-Degnen; Michael T Stevenson; Sarah D Gunnery; Marie Saint-Hilaire; Cathi A Thomas; Linda Sprague Martinez; Barbara Habermann; Elena N Naumova
Journal:  Disabil Rehabil       Date:  2020-04-01       Impact factor: 3.033

4.  Utilization of rehabilitation therapy services in Parkinson disease in the United States.

Authors:  Michelle E Fullard; Dylan P Thibault; Andrew Hill; Joellyn Fox; Danish E Bhatti; Michelle A Burack; Nabila Dahodwala; Elizabeth Haberfeld; Drew S Kern; Olga S Klepitskava; Enrique Urrea-Mendoza; Phillip Myers; Jay Nutt; Miriam R Rafferty; Jason M Schwalb; Lisa M Shulman; Allison W Willis
Journal:  Neurology       Date:  2017-08-23       Impact factor: 9.910

Review 5.  Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Authors:  Rejko Krüger; Jochen Klucken; Daniel Weiss; Lars Tönges; Pierre Kolber; Stefan Unterecker; Michael Lorrain; Horst Baas; Thomas Müller; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2017-03-24       Impact factor: 3.575

6.  Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson's Disease Patients.

Authors:  Martin Klietz; Amelie Tulke; Lars H Müschen; Lejla Paracka; Christoph Schrader; Dirk W Dressler; Florian Wegner
Journal:  Front Neurol       Date:  2018-03-06       Impact factor: 4.003

7.  Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.

Authors:  Jennifer Y Y Szeto; Courtney C Walton; Alexandra Rizos; Pablo Martinez-Martin; Glenda M Halliday; Sharon L Naismith; K Ray Chaudhuri; Simon J G Lewis
Journal:  NPJ Parkinsons Dis       Date:  2020-01-07

8.  Clinical Profile of Chinese Long-Term Parkinson's Disease Survivors With 10 Years of Disease Duration and Beyond.

Authors:  Qian Sun; Tian Wang; Tian-Fang Jiang; Pei Huang; Ying Wang; Qin Xiao; Jun Liu; Sheng-Di Chen
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

Review 9.  Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.

Authors:  Nataliya Titova; Pablo Martinez-Martin; Elena Katunina; K Ray Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2017-11-07       Impact factor: 3.575

10.  Clinical classification systems and long-term outcome in mid- and late-stage Parkinson's disease.

Authors:  Emil Ygland Rödström; Andreas Puschmann
Journal:  NPJ Parkinsons Dis       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.